Literature DB >> 34930627

Recent Advancements in CT and MR Imaging of Prostate Cancer.

Asha Daryanani1, Baris Turkbey2.   

Abstract

CT and MRI are both commonly used in prostate cancer (PCa) management, which includes a large spectrum from screening positive pre-diagnosis phase to metastatic disease. CT and MRI have continually evolved to meet the changing demands for PCa management. For CT, novel techniques such as dual energy CT and photon counting CT show promising results for tissue characterization and quantification. For MRI, the detection, staging, and management of prostate cancer has been significantly improved by the development of multiparametric, biparametric, and whole-body MRI techniques. Additionally, research on ultrasmall superparamagnetic particles of iron oxide contrast-enhanced MRI has revealed promising results for nodal staging of PCa. In this manuscript we aim to outline the current status and recent advancements of CT and MRI in PCa imaging.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2021        PMID: 34930627      PMCID: PMC9038642          DOI: 10.1053/j.semnuclmed.2021.11.013

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.802


  39 in total

1.  Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds.

Authors:  Baris Turkbey; Haresh Mani; Vijay Shah; Ardeshir R Rastinehad; Marcelino Bernardo; Thomas Pohida; Yuxi Pang; Dagane Daar; Compton Benjamin; Yolanda L McKinney; Hari Trivedi; Celene Chua; Gennady Bratslavsky; Joanna H Shih; W Marston Linehan; Maria J Merino; Peter L Choyke; Peter A Pinto
Journal:  J Urol       Date:  2011-09-25       Impact factor: 7.450

2.  Dramatic increase in the utilization of multiparametric magnetic resonance imaging for detection and management of prostate cancer.

Authors:  Daniel T Oberlin; David D Casalino; Frank H Miller; Joshua J Meeks
Journal:  Abdom Radiol (NY)       Date:  2017-04

3.  Dosimetric impact of dual-energy CT tissue segmentation for low-energy prostate brachytherapy: a Monte Carlo study.

Authors:  Charlotte Remy; Arthur Lalonde; Dominic Béliveau-Nadeau; Jean-François Carrier; Hugo Bouchard
Journal:  Phys Med Biol       Date:  2018-01-11       Impact factor: 3.609

4.  Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?

Authors:  Baris Turkbey; Vijay P Shah; Yuxi Pang; Marcelino Bernardo; Sheng Xu; Jochen Kruecker; Julia Locklin; Angelo A Baccala; Ardeshir R Rastinehad; Maria J Merino; Joanna H Shih; Bradford J Wood; Peter A Pinto; Peter L Choyke
Journal:  Radiology       Date:  2010-12-21       Impact factor: 11.105

5.  Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection.

Authors:  Alberto Briganti; Firas Abdollah; Alessandro Nini; Nazareno Suardi; Andrea Gallina; Umberto Capitanio; Marco Bianchi; Manuela Tutolo; Niccolò Maria Passoni; Andrea Salonia; Renzo Colombo; Massimo Freschi; Patrizio Rigatti; Francesco Montorsi
Journal:  Eur Urol       Date:  2011-11-12       Impact factor: 20.096

6.  Abbreviated Biparametric Prostate MR Imaging in Men with Elevated Prostate-specific Antigen.

Authors:  Christiane K Kuhl; Robin Bruhn; Nils Krämer; Sven Nebelung; Axel Heidenreich; Simone Schrading
Journal:  Radiology       Date:  2017-07-20       Impact factor: 11.105

Review 7.  Recognizing and Minimizing Artifacts at Dual-Energy CT.

Authors:  Anushri Parakh; Chansik An; Simon Lennartz; Prabhakar Rajiah; Benjamin M Yeh; Frank J Simeone; Dushyant V Sahani; Avinash R Kambadakone
Journal:  Radiographics       Date:  2021-02-19       Impact factor: 5.333

Review 8.  PET/MRI in prostate cancer: a systematic review and meta-analysis.

Authors:  Laura Evangelista; Fabio Zattoni; Gianluca Cassarino; Paolo Artioli; Diego Cecchin; Fabrizio Dal Moro; Pietro Zucchetta
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-09-08       Impact factor: 9.236

9.  Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P): inter-observer agreement between readers of different expertise levels.

Authors:  Paola Pricolo; Eleonora Ancona; Paul Summers; Jorge Abreu-Gomez; Sarah Alessi; Barbara Alicja Jereczek-Fossa; Ottavio De Cobelli; Franco Nolè; Giuseppe Renne; Massimo Bellomi; Anwar Roshanali Padhani; Giuseppe Petralia
Journal:  Cancer Imaging       Date:  2020-10-27       Impact factor: 3.909

10.  Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.

Authors:  Michael S Hofman; Nathan Lawrentschuk; Roslyn J Francis; Colin Tang; Ian Vela; Paul Thomas; Natalie Rutherford; Jarad M Martin; Mark Frydenberg; Ramdave Shakher; Lih-Ming Wong; Kim Taubman; Sze Ting Lee; Edward Hsiao; Paul Roach; Michelle Nottage; Ian Kirkwood; Dickon Hayne; Emma Link; Petra Marusic; Anetta Matera; Alan Herschtal; Amir Iravani; Rodney J Hicks; Scott Williams; Declan G Murphy
Journal:  Lancet       Date:  2020-03-22       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.